These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9123368)

  • 1. Pretransplant and posttransplant monitoring of anti-HLA class I IgG1 antibodies by ELISA identifies patients at high risk of graft loss.
    Monteiro F; Mineiro C; Rodrigues H; de Paula FJ; Kalil J
    Transplant Proc; 1997; 29(1-2):1433-4. PubMed ID: 9123368
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of patients at high risk of graft loss by pre- and posttransplant monitoring of anti-HLA class I IgG antibodies by enzyme-linked immunosorbent assay.
    Monteiro F; Buelow R; Mineiro C; Rodrigues H; Kalil J
    Transplantation; 1997 Feb; 63(4):542-6. PubMed ID: 9047148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretransplant rejection risk assessment through enzyme-linked immunosorbent assay analysis of anti-HLA class I antibodies.
    Regan J; Monteiro F; Speiser D; Kalil J; Pouletty P; Buelow R
    Am J Kidney Dis; 1996 Jul; 28(1):92-8. PubMed ID: 8712228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can anti-HLA antibody analyses postcardiac transplantation predict acute allograft rejection and survival?
    Bhat G; Schroeder TJ; Balakrishnan K
    Transplant Proc; 1998 Jun; 30(4):1154-7. PubMed ID: 9636467
    [No Abstract]   [Full Text] [Related]  

  • 6. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of anti-HLA and anti-Major histocompatibility complex class I related chain A antibodies in living related renal donor transplantation.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Transplant Proc; 2007 Apr; 39(3):759-60. PubMed ID: 17445592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttransplant immune monitoring of anti-HLA antibody.
    Kerman RH; Katz SM; Van Buren CT; Ruth J; McKissick E; Rasmussen S; Kahan BD
    Transplant Proc; 2001; 33(1-2):402. PubMed ID: 11266882
    [No Abstract]   [Full Text] [Related]  

  • 10. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
    Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
    Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of HLA class I and II antibodies by ELISA and complement-dependent cytotoxicity before and after transplantation.
    Christiaans MH; Nieman F; van Hooff JP; van den Berg-Loonen EM
    Transplantation; 2000 Mar; 69(5):917-27. PubMed ID: 10755551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss.
    Rodríguez LM; París SC; Arbeláez M; Cotes JM; Süsal C; Torres Y; García LF
    Hum Immunol; 2007 Aug; 68(8):652-60. PubMed ID: 17678719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of clinically relevant antibodies pretransplant and posttransplant with PRA-STAT. The Anti-CD45 Study Group.
    Neylan J; de Smet W; Stijlemans B; Brinker K; Gonwa T; Moran J; Segers A
    Transplant Proc; 1997; 29(1-2):330-2. PubMed ID: 9123025
    [No Abstract]   [Full Text] [Related]  

  • 14. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.
    Cai J; Terasaki PI; Anderson N; Lachmann N; Schönemann C
    Transplantation; 2009 Jul; 88(2):226-30. PubMed ID: 19623018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flashback to 2002: a retesting and reanalysis suggests an important role of DSA.
    Reyes N
    Clin Transpl; 2012; ():257-60. PubMed ID: 23721030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of donor-specific class-I anti-HLA antibodies detected by ELISA after kidney transplantation on the development of acute rejection and graft survival.
    Fernández-Fresnedo G; Pastor JM; López-Hoyos M; Ruiz JC; Zubimendi JA; Gonzalez-Cotorruelo J; Rodrigo E; De Francisco AL; Arias M
    Nephrol Dial Transplant; 2003 May; 18(5):990-5. PubMed ID: 12686676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of IgG HLA antibodies in patients with long-surviving renal allografts.
    Norman PJ; Harmer AW; Koffman CG; Vaughan RW
    Transplant Proc; 1995 Feb; 27(1):999-1000. PubMed ID: 7879260
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoglobulin class switch of posttransplant panel reactive antibody and the impact on kidney allograft outcome.
    Sumethkul V; Mongkolsuk T; Sujirachato K; Chiewsilp P
    Transplant Proc; 1998 Jun; 30(4):1167. PubMed ID: 9636471
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological monitoring of posttransplant allograft sensitization following living related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Tiwari SC; Mehra NK
    Transplant Proc; 2004 Jun; 36(5):1336-9. PubMed ID: 15251326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
    Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
    Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.